Andrew Booth

Insider Reports History

Entity
Individual
Location
C/O Abcellera Biologics Inc., 2215 Yukon Street, Vancouver, British Columbia, Canada
Signature
Tryn Stimart, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Booth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AbCellera Biologics Inc. Chief Financial Officer Share option (right to buy) 7.94M $92.4M $14.02 Jan 1, 2025 Direct

Insider Reports Filed by Andrew Booth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABCL AbCellera Biologics Inc. Jan 1, 2025 1 $0 4 Jan 3, 2025 Chief Financial Officer
ABCL AbCellera Biologics Inc. Jan 14, 2024 1 $0 4 Jan 16, 2024 Chief Financial Officer
ABCL AbCellera Biologics Inc. May 26, 2023 1 $99.3K 4 May 26, 2023 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 20, 2022 3 $9.5K 4 Dec 22, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 1, 2022 1 $0 4 Dec 5, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. May 12, 2022 1 $492K 4 May 16, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 31, 2021 1 $0 5 Feb 3, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 10, 2021 2 $160K 4 Dec 10, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 7, 2021 1 $0 4 Dec 9, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Nov 11, 2021 2 $993K 4 Nov 15, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Jun 9, 2021 1 -$30.6M 4 Jun 10, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Jun 7, 2021 4 $306K 4 Jun 9, 2021 Chief Financial Officer